EP
GDRX icon

Essential Partners’s GoodRx Holdings GDRX Stock Holding History

Essential Partners’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.2K Sell
1,883
-1,967
-51% -$6.55K ﹤0.01% 1415
2026
Q2 		$11.1K Sell
3,850
-10,454
-73% -$26.6K 0.01% 1176
2026
Q1 		$28K Buy
14,304
+11,295
+375% +$26.5K 0.01% 799
2025
Q4 		$8.15K Buy
3,009
+2,763
+1,123% +$9.07K ﹤0.01% 1243
2025
Q3 		$1.04K Buy
246
+153
+165% +$673 ﹤0.01% 2012
2025
Q2 		$463 Buy
+93
New +$404 ﹤0.01% 1723

Other funds holding GDRX

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
LWM
Lodestone Wealth Management Spokane, Washington $297M AUM 25.27% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return

Essential Partners's GDRX Position: Q3 2026 in Review

Essential Partners reduced its GoodRx Holdings (GDRX) stake by 51% in Q3 2026, selling an estimated $6.55K and leaving 1,883 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Essential Partners first reported a position in GDRX in Q2 2025 and has held it in 6 quarters since. The position peaked at $28K in Q1 2026. 8 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • Essential Partners held 1,883 shares of GoodRx Holdings worth $6.2K as of Q3 2026.
  • Essential Partners sold 1,967 GoodRx Holdings shares in Q3 2026, an estimated $6.55K.
  • GoodRx Holdings made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1415 holding.
  • Essential Partners first reported a position in GoodRx Holdings in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's GoodRx Holdings position peaked at $28K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.